Incidental Mutation 'R2150:Parvb'
ID 234223
Institutional Source Beutler Lab
Gene Symbol Parvb
Ensembl Gene ENSMUSG00000022438
Gene Name parvin, beta
Synonyms D15Gsk1, affixin
MMRRC Submission 040153-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R2150 (G1)
Quality Score 225
Status Validated
Chromosome 15
Chromosomal Location 84116244-84199889 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) A to G at 84116369 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Lysine to Glutamic Acid at position 33 (K33E)
Ref Sequence ENSEMBL: ENSMUSP00000023072 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000023072] [ENSMUST00000122818]
AlphaFold Q9ES46
Predicted Effect possibly damaging
Transcript: ENSMUST00000023072
AA Change: K33E

PolyPhen 2 Score 0.629 (Sensitivity: 0.87; Specificity: 0.91)
SMART Domains Protein: ENSMUSP00000023072
Gene: ENSMUSG00000022438
AA Change: K33E

DomainStartEndE-ValueType
low complexity region 2 14 N/A INTRINSIC
CH 90 190 3.46e-1 SMART
low complexity region 204 211 N/A INTRINSIC
CH 257 360 9.18e-2 SMART
Predicted Effect unknown
Transcript: ENSMUST00000122818
AA Change: K33E
SMART Domains Protein: ENSMUSP00000117594
Gene: ENSMUSG00000022438
AA Change: K33E

DomainStartEndE-ValueType
low complexity region 2 14 N/A INTRINSIC
Meta Mutation Damage Score 0.0703 question?
Coding Region Coverage
  • 1x: 99.2%
  • 3x: 98.7%
  • 10x: 97.5%
  • 20x: 95.6%
Validation Efficiency 98% (59/60)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the parvin family of actin-binding proteins, which play a role in cytoskeleton organization and cell adhesion. These proteins are associated with focal contacts and contain calponin homology domains that bind to actin filaments. This family member binds to alphaPIX and alpha-actinin, and it can inhibit the activity of integrin-linked kinase. This protein also functions in tumor suppression. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011]
PHENOTYPE: Disruption of this marker has no apparent adverse consequences. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 56 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
4933402J07Rik C T 8: 88,312,691 (GRCm39) Q159* probably null Het
Abca12 C A 1: 71,302,647 (GRCm39) V2191L probably benign Het
Adam34 A G 8: 44,105,538 (GRCm39) Y36H probably benign Het
Adprm A G 11: 66,929,055 (GRCm39) V312A probably benign Het
Anapc2 T C 2: 25,162,682 (GRCm39) L52P probably benign Het
Anxa2 TCCC TCC 9: 69,397,036 (GRCm39) probably null Het
Apoc4 T A 7: 19,412,560 (GRCm39) T62S probably damaging Het
Arfgef1 C T 1: 10,270,103 (GRCm39) A349T probably benign Het
Arhgap32 A G 9: 32,027,436 (GRCm39) E2G possibly damaging Het
Atg4c C A 4: 99,109,463 (GRCm39) N143K possibly damaging Het
C1qtnf12 A G 4: 156,050,922 (GRCm39) N297S probably benign Het
Cadps2 G T 6: 23,838,998 (GRCm39) probably benign Het
Ccdc63 C G 5: 122,265,628 (GRCm39) A71P possibly damaging Het
Cdca2 T C 14: 67,952,258 (GRCm39) K38E probably damaging Het
Cyp2j11 G A 4: 96,204,595 (GRCm39) T317I probably damaging Het
Dab2 T C 15: 6,446,398 (GRCm39) V5A probably benign Het
Dennd3 A T 15: 73,426,909 (GRCm39) H762L probably benign Het
Disp1 A G 1: 182,869,936 (GRCm39) F828S probably damaging Het
Dnah2 T C 11: 69,406,587 (GRCm39) M552V probably benign Het
Dock2 A G 11: 34,179,472 (GRCm39) probably null Het
Dsel A T 1: 111,787,987 (GRCm39) N849K probably benign Het
Fah A T 7: 84,244,042 (GRCm39) I239N probably damaging Het
Flt4 T C 11: 49,536,824 (GRCm39) Y1265H probably benign Het
Ghdc T C 11: 100,660,018 (GRCm39) E243G probably benign Het
Glb1 T C 9: 114,279,716 (GRCm39) Y375H probably damaging Het
Gm6619 A G 6: 131,466,021 (GRCm39) I40V probably benign Het
Gpld1 T C 13: 25,146,630 (GRCm39) V225A probably benign Het
Hectd4 T C 5: 121,391,921 (GRCm39) probably benign Het
Igdcc4 A G 9: 65,032,617 (GRCm39) I542V possibly damaging Het
Igsf9b T C 9: 27,245,633 (GRCm39) L1200P probably damaging Het
Itgb7 C T 15: 102,130,553 (GRCm39) V378M probably damaging Het
Krt84 T C 15: 101,438,019 (GRCm39) E312G possibly damaging Het
Man2a2 A G 7: 80,017,532 (GRCm39) W250R probably damaging Het
Mcam T C 9: 44,047,932 (GRCm39) V59A probably damaging Het
Mfrp T C 9: 44,015,015 (GRCm39) L314P probably benign Het
Mgat5 T C 1: 127,396,987 (GRCm39) V578A probably damaging Het
Mycbp2 G A 14: 103,393,358 (GRCm39) H3068Y probably damaging Het
Myh1 A C 11: 67,113,234 (GRCm39) D1873A probably benign Het
Nek9 A G 12: 85,376,677 (GRCm39) W235R probably damaging Het
Or9g19 T C 2: 85,600,342 (GRCm39) S66P probably damaging Het
Pecr T C 1: 72,316,517 (GRCm39) R63G possibly damaging Het
Pkhd1l1 T G 15: 44,363,378 (GRCm39) probably null Het
Plekha5 T C 6: 140,516,129 (GRCm39) V270A probably damaging Het
Prr14l T C 5: 32,988,046 (GRCm39) D483G probably benign Het
Rimkla T A 4: 119,331,779 (GRCm39) M140L possibly damaging Het
Senp1 C T 15: 97,956,196 (GRCm39) V408I possibly damaging Het
Stambpl1 T A 19: 34,204,104 (GRCm39) Y65N probably damaging Het
Tada2a T C 11: 83,970,455 (GRCm39) D432G probably damaging Het
Themis T A 10: 28,544,723 (GRCm39) I23N probably damaging Het
Thnsl1 T C 2: 21,217,344 (GRCm39) I366T probably benign Het
Tmem131 C A 1: 36,851,690 (GRCm39) V938L probably benign Het
Tmem178b A T 6: 40,184,435 (GRCm39) Q111L probably damaging Het
Vmn1r195 C G 13: 22,462,934 (GRCm39) L135V possibly damaging Het
Vmn2r-ps36 C T 7: 7,431,539 (GRCm39) noncoding transcript Het
Zfp956 G A 6: 47,940,805 (GRCm39) R388H probably damaging Het
Zfr2 T G 10: 81,077,950 (GRCm39) V259G probably benign Het
Other mutations in Parvb
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01610:Parvb APN 15 84,187,666 (GRCm39) missense probably damaging 1.00
IGL02415:Parvb APN 15 84,177,016 (GRCm39) missense probably damaging 1.00
IGL02458:Parvb APN 15 84,187,635 (GRCm39) missense probably damaging 1.00
IGL02937:Parvb APN 15 84,193,154 (GRCm39) missense probably damaging 1.00
IGL03088:Parvb APN 15 84,193,044 (GRCm39) splice site probably benign
R0422:Parvb UTSW 15 84,179,812 (GRCm39) missense probably benign 0.28
R1470:Parvb UTSW 15 84,155,453 (GRCm39) missense probably damaging 1.00
R1470:Parvb UTSW 15 84,155,509 (GRCm39) missense probably benign 0.00
R1470:Parvb UTSW 15 84,155,509 (GRCm39) missense probably benign 0.00
R1470:Parvb UTSW 15 84,155,453 (GRCm39) missense probably damaging 1.00
R1713:Parvb UTSW 15 84,182,192 (GRCm39) splice site probably benign
R2031:Parvb UTSW 15 84,167,036 (GRCm39) missense probably benign 0.09
R2146:Parvb UTSW 15 84,116,369 (GRCm39) missense possibly damaging 0.63
R2148:Parvb UTSW 15 84,116,369 (GRCm39) missense possibly damaging 0.63
R2149:Parvb UTSW 15 84,116,369 (GRCm39) missense possibly damaging 0.63
R2508:Parvb UTSW 15 84,182,171 (GRCm39) missense probably benign
R4770:Parvb UTSW 15 84,188,106 (GRCm39) critical splice donor site probably null
R5948:Parvb UTSW 15 84,187,662 (GRCm39) missense probably damaging 1.00
R6492:Parvb UTSW 15 84,188,073 (GRCm39) missense probably damaging 1.00
R6718:Parvb UTSW 15 84,182,180 (GRCm39) missense probably damaging 0.96
R6719:Parvb UTSW 15 84,182,180 (GRCm39) missense probably damaging 0.96
R6720:Parvb UTSW 15 84,182,180 (GRCm39) missense probably damaging 0.96
R6722:Parvb UTSW 15 84,182,180 (GRCm39) missense probably damaging 0.96
R7189:Parvb UTSW 15 84,187,672 (GRCm39) critical splice donor site probably null
R7285:Parvb UTSW 15 84,166,985 (GRCm39) missense possibly damaging 0.94
R7492:Parvb UTSW 15 84,174,651 (GRCm39) missense probably damaging 0.98
R9046:Parvb UTSW 15 84,174,639 (GRCm39) missense probably benign 0.03
R9347:Parvb UTSW 15 84,155,523 (GRCm39) critical splice donor site probably null
R9373:Parvb UTSW 15 84,188,100 (GRCm39) missense probably damaging 0.98
R9714:Parvb UTSW 15 84,167,041 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- GACCGTACATGTTTGTGGGAC -3'
(R):5'- GCACTGCAAATGTCTTACGGAC -3'

Sequencing Primer
(F):5'- GGACTAATTGATTCTGGGCTTCC -3'
(R):5'- ACAGGGACCGGCCTGTC -3'
Posted On 2014-10-01